Mirum Pharmaceuticals, Inc. ($MIRM)
Filing Information
| Accession Number | 0001365617-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 27, 2026 |
| Document Date | Jan 23, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
290,702
Total Value
$8,999,984.00
P&L
+29.2% (+$2,632,442.75)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jan 23, 2026 | Other Acquisition or Disposition | 159,277 | โ | โ | 327,585 | Indirect | By Frazier Life Sciences X, L.P. | View Details | |
Director | Common Stock | โ | Jan 23, 2026 | Purchase | 131,425 | $68.48 | $8,999,984.00 | 459,010 | Indirect | By Frazier Life Sciences X, L.P. | View Details |